Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease-Reference-Cited by-同舟云学术

Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease

Published:2023-11 Issue: Volume:140 Page:103125
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Kishimoto Takashi Kei^ORCID,Fournier Max,Michaud Alicia,Rizzo Gina,Roy Christopher,Capela Teresa,Nukolova Natasha,Li Ning,Doyle Liam,Fu Fen-ni,VanDyke Derek,Traber Peter G.,Spangler Jamie B.,Leung Sheldon S.,Ilyinskii Petr O.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference72 articles.

1. Treg cells-the next frontier of cell therapy;Bluestone;Science,2018

2. Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation;Selck;Front. Immunol.,2021

3. Regulating the regulators: is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?;Janssens;Cell. Immunol.,2020

4. The biology of interleukin-2;Malek;Annu. Rev. Immunol.,2008

5. The surprising story of IL-2: from experimental models to clinical application;Abbas;Am. J. Pathol.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations;Frontiers in Immunology;2024-09-03

2. Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis;Frontiers in Immunology;2024-01-23

3. Comparison of emulsion and spray methods for fabrication of rapamycin-loaded acetalated dextran microparticles;RSC Pharmaceutics;2024